Population
Patients with venous thromboembolism (VTE) and acute coronary syndrome (ACS)
Design
Review
Authors
Loading...
Urges vigilant monitoring in VTE/ACS antithrombotic regimens; leaves open optimal strategies for balancing efficacy and safety.
Highlights the complexity and potential complications, such as bleeding and heparin-induced thrombocytopenia, associated with antithrombotic and antiplatelet therapies in VTE and ACS management.
Stuart T. Haines (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: